A previous study of breast cancer defined a 112-gene CSF1 response signature associated with higher tumor grade, decreased expression of estrogen receptor (ER) and progesterone receptor (PR), and higher mutation rate (Beck et al., 2009). Here, ESR1 is linked to breast carcinoma.